Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobazam as Adjunctive Therapy in Pediatric Dravet Syndrome
NCT02174094Phase 3Withdrawn
- Sponsor
- Lundbeck
- Start
- Mar 2015
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in Dravet syndrome comparing Clobazam with Placebo (2 arms). Primary endpoint: Percent change from baseline to study completion/withdrawal in seizure rate for combined tonic-clonic and clonic seizure rates at 16 weeks. Planned start Mar 2015; status: withdrawn.
02
Drugs
clobazam
03
Conditions
Dravet syndrome
Beyond the preview
Go deeper on NCT02174094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02174094.